Chief District Judge Denise J. Casper of the United States District Court for the District of Massachusetts has appointed DiCello Levitt, together with Berman Tabacco, Edelson PC, and Lieff Cabraser, as Interim Co-Lead Counsel in the consolidated class action, In re: Respimat Pharmaceuticals Antitrust Litigation (Case No. 1:25-md-03154, D. Mass.).
The litigation alleges that a pharmaceutical manufacturer thwarted generic competition for Combivent Respimat and Spiriva Respimat, both treatments for chronic obstructive pulmonary disease (COPD), by wrongfully listing its device patents in the FDA’s Orange Book. This anticompetitive conduct unlawfully delayed access to affordable generic alternatives, forcing purchasers nationwide to pay inflated prices for these essential medications. Plaintiffs contend that, but for the defendants’ conduct, generics would have been available years earlier, at significantly lower prices.
In appointing DiCello Levitt and its co-counsel, the Court recognized the firms’ substantial efforts in developing the case and their extensive experience leading complex antitrust and pharmaceutical litigation.
DiCello Levitt’s team is led by Geralyn Trujillo and includes Greg Asciolla, Chair of the firm’s Antitrust and Competition Litigation Practice Group, and Associates Jay Wexler and Noah Cozad.
